Key result
Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) represents a promising prognostic marker in patients with acute myocardial infarction, with low levels associated with worse outcomes.
Design
Review
Authors
Loading...
May support TRAIL for post-AMI risk stratification; leaves open prospective validation before clinical use.
This review emphasizes the pathophysiological role of apoptosis in ischemic heart disease and identifies TRAIL as a potentially valuable biomarker for prognostic stratification following acute myocardial infarction.
Teringová et al. (2017) conducted a review in Ischemic heart disease. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) represents a promising prognostic marker in patients with acute myocardial infarction, with low levels associated with worse outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: